TG Therapeutics, Inc. (TGTX) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for TGTX. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 416 institutions reported holding TGTX, with 111.0 million shares worth $6.1 billion in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| BlackRock | 22,050,045 | $1.2B | DECREASED |
| Vanguard | 15,326,702 | $842M | DECREASED |
| State Street | 7,786,471 | $428M | DECREASED |
| Geode Capital Management | 3,642,216 | $200M | INCREASED |
| D. E. Shaw | 3,400,808 | $187M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Laurence N Charney (Director) | SELL | 5,000 | $275K | 2026-09-10 |
Full institutional holdings, insider history, and congressional trades for TG Therapeutics, Inc. on SentiSense.